Seventy tumours (23% in the whole tumour set, 9% in Caucasian, 34% in Asian specimens) had EGFR kinase domain mutations with only one of them occurring concurrently with an LKB1 mutation (P=0.002). The gene discussed is STK11; the disease is neoplasm.